The molecular connections between the cannabinoid system and endometriosis

Ana M. Sánchez, A. M. Sanchez, P Vigano, Paola Viganò, Mugione A, A. Mugione, Paola Panina‐Bordignon, P. Panina-bordignon, M. Candiani, Massimo Candiani
Molecular human reproduction · 2012 · vol. 18(12) , pp. 563–571 · doi:10.1093/molehr/gas037 · PMID:22923487 · W2126884530
Review OA: bronze CC0 ⤵ 25 in-corpus citations
📄 Open PDF View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-10 ⓘ

This review explored the regulation and function of the endocannabinoid system in endometriosis models, finding CB1/CB2 receptors and related enzymes differentially expressed and agonists impacting cell proliferation, pain, and migration via specific signaling pathways.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

The endocannabinoid system consists of an array of endogenously produced bioactive lipids that activate cannabinoid 1 (CB1) and 2 (CB2) receptors. Alterations of this system have been described in almost every category of disease. These changes can be protective or maladaptive, making the endocannabinoid network an attractive therapeutic target. Little is known about the potential role of endocannabinoids in endometriosis development although this is a topic worthy of further investigation since endocannabinoid modulators have recently been shown to affect specific mechanisms critical to endometriosis establishment and maintenance. A literature review was herein performed with the aim of defining the regulation and function of the endocannabinoid signaling in in vitro and animal models of endometriosis. The components of the endocannabinoid system, CB1 and CB2 receptors and the enzymes N-acylphosphatidylethanolamine-phospholipase D and fatty acid amide hydrolase are differentially regulated throughout the menstrual cycle in the endometrium and are expressed in deep endometriotic nodules and in sensory and sympathetic neurons innervating the lesions. Selective cannabinoid receptor agonists, such as WIN 55212-2, appear to have a favorable action in limiting cell proliferation and in controlling pain symptoms. Conversely, endometrial cell migration tends to be stimulated by receptor agonists. The phosphatidylinositol 3-kinase/Akt and extracellular signal-regulated kinase 1/2 pathways seem to be involved in these processes. However, the underlying mechanisms of action are only just beginning to unfold. Given the complexity of the system, further studies are needed to clarify whether the endocannabinoid system might represent a promising target for endometriosis.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Cannabinoids Endometriosis Arachidonic Acids Arachidonic Acids Arachidonic Acids Cannabinoids Cannabinoids Endocannabinoids Endocannabinoids Endocannabinoids Endometriosis Endometriosis Endometrium Endometrium Endometrium Endometrium Female Female Humans Humans

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (80)

Cited by (26)

Source provenance

europepmc
last seen: 2026-10-17T06:09:56.316927+00:00
openalex
last seen: 2026-05-11T06:38:17.545654+00:00
pubmed
last seen: 2026-10-08T21:10:46.340120+00:00
License: CC0 · commercial use OK